The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Mar. 30, 2017
Applicant:

Supernus Pharmaceuticals, Inc., Rockville, MD (US);

Inventors:

Likan Liang, Boyds, MD (US);

Hua Wang, Clarksville, MD (US);

Padmanabh P. Bhatt, Rockville, MD (US);

Michael L. Vieira, Gaithersburg, MD (US);

Assignee:

SUPERNUS PHARMACEUTICALS, INC., Rockville, MD (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/50 (2006.01); A61K 31/357 (2006.01); A61K 31/7048 (2006.01); A61K 45/06 (2006.01); A61K 9/16 (2006.01); A61K 9/24 (2006.01); B82Y 5/00 (2011.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61K 9/5042 (2013.01); A61K 9/1652 (2013.01); A61K 9/1676 (2013.01); A61K 9/209 (2013.01); A61K 9/5047 (2013.01); A61K 9/5078 (2013.01); A61K 9/5084 (2013.01); A61K 31/357 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); A61K 47/6951 (2017.08); B82Y 5/00 (2013.01); Y02A 50/465 (2018.01);
Abstract

Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.


Find Patent Forward Citations

Loading…